Navigation Links
Eczema Non-Profit Seeks To Shine New Light On Overlooked Condition
Date:7/1/2012

Indian Harbour Beach, Florida (PRWEB) July 01, 2012

ITSAN, a non-profit charity, is on a mission to combat the global health crisis that is Topical Steroid Addiction. The organization’s main effort is to reach Eczema patients with information about the correlation between Topical Steroids and worsening Eczema. Topical Steroids are the main medication used to treat Eczema.

“In 30 years of practice I have seen over 2,000 patients who initially had Eczema, either in youth, teen years or early adulthood. Each patient started off using Cortisone Creams. When the initial dose and potency no longer worked they were prescribed a higher potency with more frequent usage. In addition often pills and injections of cortisone were given,” recounts Dr. Rapaport.

“In all cases we decided to stop steroids and lo and behold, in one to three years, they were all cured. However, in each case the patient experienced a painful and debilitating withdrawal. They would swell, ooze, have difficulty functioning in school or work, scratch continually, and couldn’t sleep; we had to support them with other medication and keep them off steroids,” stated Dr. Rapaport.

Kelly Palace, president and Co-Founder of ITSAN, was diagnosed in 2009 with Steroid Induced Eczema caused by her Topical Steroid Addiction. Kelly decided to start a website to chronicle her recovery and alert people of the dangers associated with Topical Steroids. Since starting the site she has had over 100,000 web visits.

“I was critically covered in full body Eczema with no recourse. I was given Corticosteroid after Corticosteroid and told there was nothing else I could do. I was getting worse and worse until I found Dr. Rapaport’s articles; he saved my life,” said ITSAN President Kelly Palace.

Kelly discovered thousands of people like her, over the Internet, suffering the same Eczema like “incurable” symptoms. Whenever they stopped applying Topical Steroids their skin would flare, burn, and turn red. “Once we each discovered the research, which depicted these exact withdrawal symptoms, we knew our cure was in sight,” said Kelly Palace.

ITSAN’s goals include educating Eczema patients about this medical issue. Gaining more recognition amongst the broader medical community about Topical Steroid Addiction. Labeling changes to Topical Steroids to better warn patients, and patient treatment options for a monitored and less painful withdrawal process.

Kelly Palace has high hopes for those who are still suffering. “We hope that if you’re suffering that you get the help and support you need from the ITSAN resources and our global, community support groups.”

To learn more about Dr. Marvin Rapaport and his research on Topical Steroid Addiction, please visit http://itsan.org/research-and-resources.html#Dr._Marvin_Rapaport

About The International Topical Steroid Addiction Network

ITSAN was officially Co-Founded by Dermatologist Dr. Marvin Rapaport, full professor at UCLA Medical Center and the nations leading expert on the subject. Kelly Palace, Co-Founder and president, was one of the 2,000 patients that Dr. Rapaport treated and cured. An online community of over 100 patients with this condition also contributed ideas, money and inspiration to start ITSAN. For more information please visit http://itsan.org

Read the full story at http://www.prweb.com/releases/2012/7/prweb9659853.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Prenatal Exposure to Common Household Chemical Linked to Eczema
2. Prenatal exposure to common household chemical increases risk for childhood eczema, study says
3. Avid Collector Seeks Jimi Hendrix 1968 Electric Factory Philadelphia Concert Poster
4. Electronic data methods research seeks to build a learning health care system
5. Trial seeks to sniff out cancer
6. FDA Seeks to Limit Antibiotics in Animal Feed
7. Lighthouse Worldwide Solutions Now Monitors Air Quality in Hospitals and Operating Rooms
8. Bees shed light on human sweet perception and metabolic disorders
9. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
10. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
11. Could Sunlight Lower Your Odds for Pancreatic Cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... City, UT (PRWEB) , ... April 24, 2017 , ... ... efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable energy. ... remedy provider. They look to nature to find solutions for health issues, and maintain ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The bar for ... those unreal icons inhabiting the rarified air of pop and film stardom.(1) Not to ... anyone snapping pictures: the smile. Grins now run the gamut from being encrusted with ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... 20, 2017  Vivify Health, the pioneer and market ... awarded a very significant patent for the advancement of ... care via digital health.  This landmark patent provides the ... further secures Vivify,s position as the leader in remote ... the first company to apply consumer mobile devices, wireless ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
Breaking Medicine Technology: